|
gptkbp:instance_of
|
gptkb:superhero
|
|
gptkbp:activities
|
opens airways
relaxes airway muscles
|
|
gptkbp:appointed_by
|
inhalation
|
|
gptkbp:approves
|
gptkb:2013
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Combivent
gptkb:Respimat
|
|
gptkbp:class
|
anticholinergic agent
beta-agonist
|
|
gptkbp:clinical_trial
|
Phase III
maintenance therapy
rescue therapy
|
|
gptkbp:contains
|
gptkb:ipratropium_bromide
albuterol
|
|
gptkbp:contraindication
|
hypersensitivity to components
|
|
gptkbp:dosage_form
|
gptkb:superhero
|
|
gptkbp:formulation
|
metered-dose inhaler
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Combivent Respimat
|
|
gptkbp:indication
|
gptkb:asthma
|
|
gptkbp:ingredients
|
gptkb:albuterol_sulfate
ipratropium
|
|
gptkbp:interacts_with
|
beta-blockers
anticholinergic drugs
other bronchodilators
|
|
gptkbp:is_available_in
|
various strengths
|
|
gptkbp:is_used_for
|
chronic obstructive pulmonary disease
|
|
gptkbp:manufacturer
|
gptkb:Boehringer_Ingelheim
|
|
gptkbp:marketed_as
|
gptkb:legislation
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:population
|
adults
children over 12
|
|
gptkbp:provides_information_on
|
gptkb:GOLD_guidelines
NICE guidelines
|
|
gptkbp:requires
|
gptkb:theorem
|
|
gptkbp:safety_features
|
not for use in children under 12
not for acute bronchospasm
|
|
gptkbp:shelf_life
|
3 years
|
|
gptkbp:side_effect
|
dizziness
headache
nausea
cough
dry mouth
skin rash
tremors
increased heart rate
palpitations
throat irritation
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:technology
|
soft mist inhaler
|
|
gptkbp:type_of_care
|
important for effectiveness
|
|
gptkbp:bfsParent
|
gptkb:formoterol
|
|
gptkbp:bfsLayer
|
5
|